Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 24 Apr 20 424B4 Prospectus supplement with pricing info
- 24 Apr 20 EFFECT Notice of effectiveness
-
23 Apr 20 S-1/A IPO registration (amended)
- 20 Apr 20 S-1/A IPO registration (amended)
- 28 Feb 20 S-1 IPO registration
ORIC similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
ORIC Pharmaceuticals, Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Diego, California
April 23, 2020